Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 289.4 | 201.1 | 131.8 | 94.9 |
| Revenue growth | 43.9% | 52.6% | 38.8% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 289.4 | 201.1 | 131.8 | 94.9 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% |
| Sales and marketing | 78.5 | 51.3 | 32.6 | 26.6 |
| Research and development | 50.3 | 31.3 | 24.5 | 15.0 |
| General and administrative | 82.9 | 61.6 | 42.7 | 34.0 |
| EBITA | -20.9 | -6.6 | -10.9 | -15.0 |
| EBITA margin | -7.2% | -3.3% | -8.3% | -15.8% |
| Amortization of intangibles | 9.1 | 6.7 | 4.9 | 2.5 |
| EBIT | -30.0 | -13.3 | -15.8 | -17.5 |
| EBIT margin | -10.4% | -6.6% | -12.0% | -18.4% |
| Pre-tax income | -37.4 | -25.9 | -18.3 | -19.6 |
| Income taxes | 2.0 | 2.2 | -7.2 | 0.6 |
| Tax rate | | | 39.2% | |
| Net income | -39.3 | -28.1 | -11.1 | -20.1 |
| Net margin | -13.6% | -14.0% | -8.4% | -21.2% |
| |
| Diluted EPS | ($0.36) | ($0.39) | ($0.60) | ($1.25) |
| Shares outstanding (diluted) | 107.9 | 71.2 | 18.4 | 16.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|